リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Reliability and Validity of the Japanese Version of the Barthel Index Dyspnea Among Patients with Respiratory Diseases」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Reliability and Validity of the Japanese Version of the Barthel Index Dyspnea Among Patients with Respiratory Diseases

Yamaguchi, Takumi Yamamoto, Akio Oki, Yutaro Sakai, Hideki Misu, Shogo Iwata, Yusuke Kaneko, Masahiro Sawada, Kaku Oki, Yukari Mitani, Yuji Ono, Kumiko Ishikawa, Akira 神戸大学

2021.07.21

概要

Purpose: Japan has only a few respiratory disease-specific activity of daily living scales that are accepted outside of Japan, and they are not widely used. The Barthel Index dyspnea (BI-d), an improved version of the Barthel Index (BI), may be popular in Japan. The purpose of this study was to develop the Japanese version of BI-d (J-BI-d) and investigate its reliability and validity. Patients and Methods: The J-BI-d was developed using the basic guidelines for scale translation. The study included patients with chronic respiratory disease, receiving outpatient care at two centers between January 2019 and February 2020. Scores on the J-BI-d, modified Medical Research Council scale (mMRC scale), BI, respiratory function tests, and 6-minute walk distance (6MWD) test were measured. To verify the test–retest reliability, the J-BI-d was re-administered, and the intraclass correlation coefficient (ICC) was obtained. Internal consistency was verified by Cronbach’s alpha reliability coefficient, and criterion-related validity was verified through a correlation analysis of the J-BI-d with mMRC scale and 6MWD test. Divergent validity was verified through correlation analysis between the J-BI-d and BI. Results: Data for 57 participants (mean age 74.4 ± 8.3 years) were analyzed, and reliability testing was performed with 42 of them. The mean time to retest was 8.1 ± 3.0 days, and the ICC (2, 1) was 0.76 (95% CI: 0.62– 0.85), indicating high reliability. Cronbach’s alpha reliability coefficient was 0.81, indicating high internal consistency. Correlation coefficients of the J-BI-d with 6MWD test (r = − 0.46, p < 0.01) and mMRC scale (ρ = 0.76, p < 0.01) indicated high criterion-related validity. The J-BI-d and BI had a weak negative correlation (r = − 0.29, p < 0.05), indicating high divergent validity. Conclusion: The results of this study demonstrate high reliability and appropriate validity of the J-BI-d in patients with chronic respiratory disease.

この論文で使われている画像

参考文献

1. O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA.

Dyspnea in COPD: new mechanistic insights and management

implications. Adv Ther. 2020;37(1):41–60. doi:10.1007/s12325-01901128-9

2. O’Donnell DE, Neder JA. The enigma of dyspnoea in COPD:

a physiological perspective. Respirology. 2020;25(2):134–136.

doi:10.1111/resp.13736

3. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation:

joint ACCP/AACVPR evidence-based clinical practice guidelines.

Chest. 2007;131(5):4S–42S. doi:10.1378/chest.06-2418

4. Vitacca M, Paneroni M. Rehabilitation of patients with coexisting

COPD and heart failure. J Chronic Obstr Pulm Dis. 2018;15

(3):231–237. doi:10.1080/15412555.2018.1468427

5. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in

disabling chronic obstructive pulmonary disease in old age. Age

Ageing. 2002;31(2):137–140. doi:10.1093/ageing/31.2.137

6. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT

statement: idiopathic pulmonary fibrosis: evidence-based guidelines

for diagnosis and management. Am J Respir Crit Care Med.

2011;183(6):788–824. doi:10.1164/rccm.2009-040GL

7. Matsuda T, Taniguchi H, Ando M, et al. COPD assessment test for

measurement of health status in patients with idiopathic pulmonary

fibrosis: a cross-sectional study. Respirology. 2017;22(4):721–727.

doi:10.1111/resp.12936

8. Nishiyama O, Taniguchi H, Kondoh Y, et al. A simple assessment of

dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis.

Eur

Respir

J.

2010;36(5):1067–1072.

doi:10.1183/

09031936.00152609

9. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global

strategy for the diagnosis, management, and prevention of chronic

obstructive pulmonary disease (2020 Report); 2020. Available from:

https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINALver1.2-03Dec19_WMV.pdf. Accessed October 5, 2020.

1870

Powered by TCPDF (www.tcpdf.org)

https://doi.org/10.2147/COPD.S313583

DovePress

Dovepress

10. Vaes AW, Delbressine JML, Mesquita R, et al. Impact of pulmonary

rehabilitation on activities of daily living in patients with chronic

obstructive pulmonary disease. J Appl Physiol. 2018;126(3):607–615.

doi:10.1152/japplphysiol.00790.2018

11. Kozu R, Senjyu H, Jenkins SC, Mukae H, Sakamoto N, Kohno S.

Differences in response to pulmonary rehabilitation in idiopathic

pulmonary fibrosis and chronic obstructive pulmonary disease.

Respiration. 2011;81(3):196–205. doi:10.1159/000315475

12. Yohannes AM, Roomi J, Waters K, Connolly MJ. A comparison of the

Barthel index and Nottingham extended activities of daily living scale

in the assessment of disability in chronic airflow limitation in old age.

Age Ageing. 1998;27(3):369–374. doi:10.1093/ageing/27.3.369

13. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel

Index for stroke rehabilitation. J Clin Epidemiol. 1989;42

(8):703–709. doi:10.1016/0895-4356(89)90065-6

14. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW.

Development and validation of a standardized measure of activity

of daily living in patients with severe COPD: the London chest

activity of daily living scale (LCADL). Respir Med. 2000;94

(6):589–596. doi:10.1053/rmed.2000.0786

15. Lareau SC, Meek PM, Roos PJ, Calif LL, Ariz T. Development and

testing of the modified version of the Pulmonary Functional Status

and Dyspnea Questionnaire (PFSDQ-M). Heart Lung. 1998;27

(3):159–168. doi:10.1016/S0147-9563(98)90003-6

16. Vitacca M, Paneroni M, Baiardi P, et al. Development of a Barthel

Index based on dyspnea for patients with respiratory diseases.

Int J Chron Obstruct Pulmon Dis. 2016;11(1):1199–1206.

doi:10.2147/COPD.S104376

17. Janaudis-Ferreira T, Beauchamp MK, Robles PG, Goldstein RS, Brooks D.

Measurement of activities of daily living in patients with COPD: a systematic

review. Chest. 2014;145(2):253–271. doi:10.1378/chest.13-0016

18. Wild D, Grove A, Martin M, et al. Principles of good practice for the

translation and cultural adaptation process for patient-reported out­

comes (PRO) measures: report of the ISPOR task force for translation

and cultural adaptation. Value Health. 2005;8(2):94–104.

doi:10.1111/j.1524-4733.2005.04054.x

19. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in

Medicine: A Practical Guide. Cambridge, England: Cambridge

University Press; 2011.

20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of

spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/

09031936.05.00034805

21. ATS Committee on Proficiency Standards for Clinical Pulmonary

Function Laboratories. ATS statement: guidelines for the six-minute

walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.

doi:10.1164/ajrccm.166.1.at1102

22. COSMIN methodology for systematic reviews of Patient-Reported

Outcome Measures (PROMs) user manual. Version 1.0 February

2018. Available from: https://www.cosmin.nl/wp-content/uploads/

COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018-1.

pdf. Accessed October 5, 2020. Accessed May 5, 2021.

23. Guyatt GH, King DR, Feeny DH, et al. Generic and specific mea­

surement of health-related quality of life in a clinical trial of respira­

tory rehabilitation. J Clin Epidemiol. 1999;52(3):187–192.

doi:10.1016/S0895-4356(98)00157-7

24. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were

proposed for measurement properties of health status

questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.

jclinepi.2006.03.012

25. de Vet HC, Terwee CB, Knol DL, et al. When to use agreement

versus reliability measures. J Clin Epidemiol. 2006;59

(10):1033–1039. doi:10.1016/j.jclinepi.2005.10.015

26. Kojima S, Ando M, Okazawa H, Sakakibara S, Hashimoto S,

Nakajima S. [Development of a Japanese version of the modified

questionnaire on the pulmonary functional status and dyspnea].

Nihon Kokyuki Gakkai Zasshi. 2004;42(6):486–490. [Japanese]

International Journal of Chronic Obstructive Pulmonary Disease 2021:16

Dovepress

27. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating

normed and standardized assessment instruments in psychology.

Psychol Assess. 1994;6(4):284–290. doi:10.1037/1040-3590.6.4.284

Yamaguchi et al

28. Bland JM, Altman DG. Statistics notes: cronbach’s alpha. BMJ.

1997;314(7080):572. doi:10.1136/bmj.314.7080.572

International Journal of Chronic Obstructive Pulmonary Disease

Dovepress

Publish your work in this journal

The International Journal of COPD is an international, peer-reviewed

journal of therapeutics and pharmacology focusing on concise rapid

reporting of clinical studies and reviews in COPD. Special focus is

given to the pathophysiological processes underlying the disease, inter­

vention programs, patient focused education, and self management

protocols. This journal is indexed on PubMed Central, MedLine

and CAS. The manuscript management system is completely online

and includes a very quick and fair peer-review system, which is

all easy to use. Visit http://www.dovepress.com/testimonials.php to

read real quotes from published authors.

Submit your manuscript here: https://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal

International Journal of Chronic Obstructive Pulmonary Disease 2021:16

Powered by TCPDF (www.tcpdf.org)

DovePress

1871

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る